Skip to main content

Table 3 Patient Demographic and Hyperhidrosis History Data From Phase 2 and Phase 3 Trials

From: Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity

Characteristic Phase 2:
DRM04-HH02 (N = 105)
Phase 3 Pooled:
ATMOS-1 & ATMOS-2
Age − 9-15 Years (N = 32) Age ≥ 16 Years (N = 665)
Age (years), mean ± SD 33.3 ± 11.7 32.7 ± 11.4 13.8 ± 1.37 33.6 ± 10.9
Axillary hyperhidrosis history (years), mean ± SD NA 15.5 ± 10.8 3.4 ± 2.77 16.1 ± 10.7
Female, n (%) 48 (45.7) 371 (53.2) 27 (84.4%) 344 (51.7)
White, n (%) 91 (86.7) 570 (81.8) 26 (81.3%) 544 (81.8)
Weekly Impact Items, n (%) responding Yes to each statement
 Change shirt during the day 79 (75.2%) N/A 517 (77.7%)
 Take more than 1 shower or bath during the day 58 (55.2%) N/A 345 (51.9%)
 Feel less confident 84 (80.0%) N/A 551 (82.9%)
 Feel embarrassed 88 (83.8%) N/A 583 (87.7%)
 Avoid interactions with others 51 (48.6%) N/A 402 (60.5%)
Prevent from doing activities 43 (41.0%) N/A 352 (52.9%)
Weekly Impact Summary,a mean ± SD 3.8 ± 1.90 N/A 4.1 ± 1.90
  1. N/A Not available, data not collected during the study course, SD Standard deviation
  2. aSummary score is derived by assigning a score of 1 for each “Yes” response (range 0 to 6). Validity of the Weekly Impact Summary score has not been tested via dimensionality analyses and should be considered exploratory at this stage
\